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Human papillomavirus (HPV) infection is highly prevalent in women migrating from coun-
tries where cervical screening is not implemented. The variety of HPV genotypes, their
prevalence and the association with cervical abnormalities has been investigated by sev-
eral groups in women moving mainly from Eastern Europe, Africa, and Southern Asia to
Italy. All studies are concordant on the elevated rate of HPV infection among immigrants,
which is four times higher than that observed among age-matched Italian women.The HPV
prevalence among short-term migrants and characterization of viral variants showed that
the high prevalence of HPV reflects either individual lifestyle or high prevalence of HPV in
the country of origin. The high burden of HPV infection correlates very well with the high
incidence of cervical cancer in migrant women. In fact, during the years 2000–2004 the
cervical cancer incidence in women from Central and Eastern Europe and living in Central
Italy was 38.3 per 100,000, which is statistically significant higher than that of native Italian
women (6 per 100,000). In this study, we pooled together the results of three independent
studies originally designed to assess the distribution and the prevalence of HPV genotypes
among 499 immigrant women living in Southern Italy. A total of 39 mucosal HPV geno-
types were identified.The 12 genotypes (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and
59) classified as carcinogenic to humans (group 1) accounted for >80% of all infections.
HPV16 was the most common viral type in all groups with frequency rates ranging from
15.4% in Africa to 51.1% in Eastern and Southern European HPV-positive women.The high
prevalence of oncogenic HPVs and cervical cancer risk among migrant women, together
with the lower participation in screening programs, demands for an urgent implementation
of preventive strategies to increase screening and vaccine coverage and viral monitoring
of uncommon HPV genotypes potential spreading in settled population.
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INTRODUCTION
Cervical cancer is the third most common cancer in women world-
wide with an estimated 530,000 new cases in 2008 (1). More
than 85% of the global burden occurs in developing countries,
including Eastern, Western, and Middle Africa, Central America,
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South-Central Asia, and Melanesia, where it is the leading cause
of cancer-related death among women (2). The etiological role
of human papillomaviruses (HPVs) in cervical cancer was first
proposed by Harald zur Hausen and his group in early 1970s (3).
Nowadays more than 50 HPV genotypes have been found to infect
the anogenital mucosa and most of them have been classified by
the International Agency for Research on Cancer (IARC) as group
1 “high-risk” viruses (HPV16, 18, 31, 33, 35, 39, 45, 51,52, 56, 58,
and 59), the 12 most frequently identified in cervical cancer; as
group 2A “probably carcinogenic” (HPV68) and group 2B “pos-
sibly carcinogenic” viruses (HPV 26, 30, 34, 53, 66, 67, 69,70, 73,
82, 85, 97), those phylogenetically related to group 1 genotypes or
presenting carcinogenic potential in mechanistic studies (4–9).
Genital HPV infections are highly prevalent among sexually
active men and women worldwide (10). The IARC HPV preva-
lence survey carried out in 15 areas in four continents showed that
oncogenic HPVs are also very common among cytological normal
women with a variation of nearly 20 times in the HPV preva-
lence depending on age groups and geographic regions (11, 12).
A large meta analysis, comprising more than one million women
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with normal cervical cytology, showed an overall HPV prevalence
of 11.7% (95% confidence interval, 11.6–11.7). The highest HPV
frequency rates were observed in Sub-Saharan Africa (24%), East-
ern Europe (21.4%), and Latin America (16.1%) (13) paralleled
by the highest incidence and mortality rates for cervical cancer.
Migrant women originating from low- and middle-income
developing countries with limited resources in their health ser-
vices and lack of cervical cytology screening programs have an
increased risk of sexual transmitted diseases and HPV-related neo-
plasia (14–16). Furthermore, a study showed that the excess risk
is only appreciable in women coming from high migration pres-
sure countries with a high prevalence of HPV (17). In Italy at the
end of 2011, there were 3536062 immigrants legally resident of
which 32% from Eastern and Central Europe, 31% from Africa,
and 25.6% from Asia1. The Eastern European countries are still
experiencing high incidence of cervical cancer, lack of appropriate
cervical cancer prevention programs, and paucity of HPV epi-
demiological surveys (13, 18, 19). Only a few studies have analyzed
HPV genotype distribution in the former Soviet Union countries
(20, 21). Tachezy et al. (22) recently reported an HPV prevalence
above 28% in the screening population of Czech women with
HPV16 as the most prevalent virus (19% of all HPV infections)
(22). No HPV prevalence studies and analysis of specific genotypes
have been performed in women residing in several other Eastern
European countries.
The aim of the current study was to describe the prevalence
of HPV infection and the distribution of oncogenic genotypes in
migrant women living in Italy along with the prevalence of HPV-
related cervical neoplasia. The analysis was based on the three
prospective studies including migrant women enrolled in Apulia,
Campania, and Sicily (23–25) and one retrospective study includ-
ing cases of invasive cancer in Italian women and in those born
abroad (26).
MATERIALS AND METHODS
STUDY SUBJECTS AND LABORATORY TEST
Published data on the analysis of HPV type distribution in migrant
women living in Italy were searched in Medline using the terms
[“HPV” OR (“human” AND “Papillomavirus”)] AND (“migrant”
OR“immigrant”OR“foreign”OR“asylum”) AND (“Italy”). When
data were published more than once, only the publication with
the largest sample size was included. Additional relevant refer-
ences cited in retrieved articles were also evaluated. For the studies
including women originating from more than one geographic
location, the data were divided into components for each con-
tinent. The review was limited to studies that (1) included the
analysis of cytological samples or paraffin embedded cancer tis-
sues obtained from migrant women living in Italy; (2) provided
cytological/histological grading; and (3) used broad spectrum
HPV–DNA-based PCR assays able to detect and genotype at least
the 12 high-risk HPVs included in the group 1. The search was
updated on 15 November 2013.
Four studies fulfilled the inclusion criteria. (1) The study by
Chironna et al. (23) analyzed 150 migrant women, housed in the
1http://demo.istat.it/altridati/noncomunitari/index.html
Asylum Seekers Center in Bari Palese (Apulia, South Italy). Among
the 168 foreign women received and examined by the Center’s
medical staff in the asylum during the period May to August 2010,
89% accepted to participate in the study. The women, after obtain-
ing informed consent, underwent cervical cytological screening
(Pap test) and HPV testing with the Linear Array HPV genotyping
test (Roche Diagnostics, Milan, Italy) able to identify HPV geno-
types 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55,
56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73, 81, 82, 83, 84,
IS39 (82), and CP6108 (cand 89). (2) The study by Tornesello et al.
(24) included 233 foreign women living in Campania region and
enrolled at Pineta Grande Hospital from January through October
2004,and at the Federico II University from February 2007 through
March 2010. HPV detection and genotyping were carried out using
broad spectrum PCR with the modified general primers MGP fol-
lowed by direct sequencing analysis/reverse line blot (RLB). The
system was evaluated as proficient for detection of HPV 16, 18,
31, 33, 35, 39, 45, 52, 56, 58, 59, 66, and 68b2. (3) The study by
Giovannelli et al. (25) included 115 migrant women who consecu-
tively attended the outpatient clinic of Dipartimento di Medicina
Clinica e delle Patologie Emergenti at the Policlinico University of
Palermo between December 2007 and June 2008. All samples were
tested using two systems for HPV identification and typing, the
INNO-LiPA HPV Genotyping system (Innogenetics N.V., Ghent,
Belgium),detecting 24 different HPV types and the wide-spectrum
nested PCR assay with MY09/11 and GP05+/06+ primers fol-
lowed by direct nucleotide sequencing analysis. (4) The pooled
analysis of three studies evaluating the HPV prevalence in invasive
cervical cancer in Italy by Giorgi Rossi et al. (26) included 526
Italian women and 48 women born abroad. In the three studies
different PCR-based strategies were used for HPV detection and
genotyping, however, the search for at least the 18 oncogenic and
probably oncogenic HPV genotypes was achieved in each study
(27–29).
STATISTICAL ANALYSIS
The frequency of each HPV genotype in cancer cases from Ital-
ian women (expected) was compared with the frequency of the
corresponding genotype in cancers from born abroad women
(observed). Ratios of observed and expected frequencies were cal-
culated for each genotype and contingency tables were used to test
for statistical significance with χ2 test, 1 degree of freedom.
RESULTS
A total of 499 cervical cytology samples and 46 cancer biopsies
from foreign women living in Italy were included from the orig-
inal studies (Table 1). The overall prevalence of HPV infection
in foreign women was 51.1% (255 out of 499) among cytological
specimens and 95.8% (46 out of 48) in cervical cancer. In Apulia
region above 89% of women housed at the Asylum Seekers Center
in Bari gave their consent to participate to the study. The mean age
of enrolled women was 24± 4 years (range 13–41) and abnormal
cytology was found in 4.4% (four ASCUS and one low SIL) of
migrants with an overall HPV prevalence of 39.1%. The migrants
2http://www.who.int
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Table 1 | Regional distribution and overall HPV prevalence among 499 migrants enrolled in three Italian regions: Apulia, Campania, and Sicily.
Region and country of origin Normal
cytology
Norm cytol
HPV-pos
SILa SIL
HPV-pos
Total Total
HPV-pos
Reference
N N (%) N N (%) N N (%)
SOUTHERN AND EASTERN EUROPE
Albania (n = 6), Byelorussia (n = 1), Bulgaria (n = 12), Macedonia
(n = 2), Moldova (n = 1), Poland (n = 6), Romania (n = 11), Russia
(n = 17), Serbia (n = 3), Ukraine (n = 95)
139 78 (56.1) 15 14 (93.3) 154 92 (59.7) Tornesello et al. (24)
Eastern Europe (n = 55) 55 28 (50.9) Giovannelli et al. (25)
SOUTHERN AND CENTRAL AMERICA
Peru (n = 1), Ecuador (n = 1), Colombia (n = 2), Brazil (n = 2),
Uruguay (n = 1), S. Domingo (n = 1)
8 5 (62.5) 8 5 (62.5) Tornesello et al. (24)
AFRICA
Tunisia (n = 2), Nigeria (n = 46), Morocco (n = 1), Ivory Coast
(n = 2), Congo (n = 1), Benin (n = 1), Ethiopia (1), Mozambique
(n = 1), Republic South Africa (n = 1)
54 30 (55.5) 2 2 (100) 56 32 (57.1) Tornesello et al. (24)
Nigeria, Ivory Cost and Mali (n = 141); Somalia, Eritrea (n = 40) 109 39 (35.8) 5 4 (80) 151 59 (39.1) Chironna et al. (23)
Sub-Saharan Africa (n = 60) 60 28 (46.7) Giovannelli et al. (25)
SOUTHERN ASIA
Sri Lanka (n = 8), Kyrgyzstan (n = 6), Philippines (n = 1) 15 11 (73.3) 15 11 (73.3) Tornesello et al. (24)
Total 325 163 (50.1) 22 20 (90.9) 499 255 (51.1)
aSIL (squamous intraepithelial lesion) comprises all cytological abnormalities. ASCUS (atypical cells of undetermined significance, low grade SIL and high grade SIL).
enrolled in Campania region, self-referring for care to the gyneco-
logic clinics, had a mean age of 37.6± 10.8 years (range 20–69) and
7.3% presented cervical cytological abnormalities (ASCUS n= 2;
low SIL n= 12; high SIL n= 3). The prevalence rates of HPV
infection were 57.9 and 94.1% among women with normal and
abnormal cytology, respectively. In Sicily foreign women, enrolled
among those self-referring for gynecologic care, the median age
was 31.2 years (range 22–55) and the frequency of cases with
abnormal cytology was 23.5% (27 out of 115). HPV prevalence
was 42% (37 out of 88) and 66.7% (18 out of 27) in women with
normal and abnormal cytology, respectively. Age-stratified HPV
prevalence in the three regions showed a higher infection rate
at younger ages with peaks of 53.1% among women ≤20 years
old in Apulia and 70 and 68.3% in women aged 21–24 and 25–
29, respectively, in Campania region, and 72.4% among women
aged 22–27 in Sicily (Table 2). The prevalence declined to 33%
in migrant women >30 years of age in Apulia and Sicily and
remained above 55% in women enrolled in Campania region.
Age-specific HPV distribution stratified by geographical origin
showed in the 21–24 and 25–29 age groups a higher frequency
of HPV infection in Southern and Eastern Europe women (71.4
and 78.6%, respectively) compared with Africa women (48.2 and
48.8%, respectively), Table 3. Among the 48 women affected by
cervical cancer and born abroad, the mean age (45.9± 11.8, range
31–70) was significantly lower than that of Italian women with
cervical cancer (mean age 52.0± 14.5, range 21–97) (p= 0.0049).
Thirty-nine different genotypes have been identified and
among them the overall prevalence of group 1 HPVs (type 16,
18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59), was 31.2, 48.9, and
43.5% in women from Apulia, Campania, and Sicily, respectively.
The most common viral genotypes were HPV16 and HPV31 rep-
resenting 27 and 8.5% of all infections, respectively. The relative
frequencies of specific genotypes in migrant women from Apulia,
Campania, and Sicily were quite comparable except for HPV59
representing 8.5% of infections in Apulia women and absent in
other groups, and HPV16, highly prevalent in Campania (43.6%
of all infections) compared to Apulia (11.9%) and Sicily (16.4%)
migrant women (Table 2).
The frequency of HPV infection and distribution of specific
genotypes among the 499 migrant women stratified by the geo-
graphical origin is shown in Table 3. HPV sequences were ampli-
fied in 51.9% (259 out of 499) of the samples with detection
rates of 44% (91 out of 207) in Africa, 59.7% (92 out of 154)
in Southern and Eastern Europe, 62.5% (5 out of 8) in Southern
and Central America, and 73.3% (11 out of 15) in Southern Asia
women. The overall prevalence of group 1 high-risk HPVs, includ-
ing the fraction contributed by multiple infections, was 39.3% in
all migrant women, 33.3% in women from Africa, 50% in those
from Southern and Eastern Europe, 50% in those from Central
America and 66.7% in women from Southern Asia (Table 3). As
expected, HPV16 was the most prevalent genotype representing
15.4, 51.1, 40, and 45.5% of all infections in Africa, Southern
and Eastern Europe, Southern and Central America, and South-
ern Asia, respectively. Other common viral types were HPV31 in
Southern and Eastern European (10.9%) and HPV58 in African
HPV-positive women (9.9%). Of note, the probable high-risk
HPV53 was particularly frequent in African women representing
12.1% of all infections.
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Table 2 |Type-specific HPV prevalence among migrant women with or
without cervical abnormalities enrolled in Apulia (n = 151), in
Campania (n = 233), and in Sicily (n = 115) region.
HPV type Apulia Campania Sicily
N (%)a
HPV-neg 92 (60.9) 93 (39.9) 60 (52.2)
HPV-pos 59 (39.1) 140 (60.1) 55 (47.8)
HPV group 1-posb 48 (31.2) 114 (48.9) 50 (43.5)
HPV-POS BY AGE
≤20 17 (53.1) 2 (100)
21–24 26 (41.3) 14 (70.0) 21 (72.4)c
25–29 12 (29.3) 28 (68.3) 15 (51.7)d
>30 4 (33.3) 96 (56.5) 19 (33.3)e
HPV GROUP 1b
16 7 (11.9) 61 (43.6) 9 (16.4)
18 3 (5.1) 2 (1.4) 7 (12.7)
31 4 (6.8) 13 (9.3) 5 (9.1)
33 1 (1.7) 5 (3.6) 2 (3.6)
35 5 (8.5) 3 (2.1) 2 (3.6)
39 5 (8.5) 2 (1.4) 4 (7.3)
45 5 (8.5) 3 (2.1) 3 (5.5)
51 5 (8.5) 1 (0.7) 7 (12.7)
52 3 (5.1) 7 (5.0) 6 (10.9)
56 2 (3.4) 8 (5.7) 2 (3.6)
58 5 (8.5) 9 (6.4) 3 (5.5)
59 3 (5.1)
HPV GROUP 2–3
6 1 (1.7) 2 (1.4) 2 (3.6)
11 1 (1.8)
26 1 (1.7)
32 1 (0.7)
40 1 (1.7) 1 (1.8)
42 61 (0.2) 2 (1.4) 1 (1.8)
43 1 (1.8)
44 2 (1.4) 4 (7.3)
53 8 (13.6) 9 (6.4) 5 (9.1)
54 5 (8.5) 3 (2.1) 3 (5.5)
55 3 (5.1)
61 6 (10.2) 1 (0.7)
62 3 (5.1) 3 (2.1)
64 1 (1.7)
66 5 (8.5) 2 (1.4) 4 (7.3)
67 2 (3.4) 2 (1.4)
68 5 (8.5) 2 (1.4) 5 (9.1)
70 3 (5.1) 8 (5.7) 2 (3.6)
72 2 (3.4)
73 2 (3.4) 1 (0.7)
74 3 (5.5)
81 6 (10.2) 2 (1.4) 2 (3.6)
82 5 (8.5)
83 1 (1.7) 4 (2.9) 2 (3.6)
84 5 (8.5) 1 (1.8)
(Continued)
HPV type Apulia Campania Sicily
N (%)a
90 1 (0.7)
cand89 3 (5.1) 3 (5.5)
aPercentages of individual HPV genotypes are calculated over the total number of
HPV-positive women in each geographical region. The sum of the different HPV
types exceeds the total number of HR HPV-positive due to multiple infections.
bHPV classification is presented in accordance to the risk assessed by the IARC
Monograph working group (6).
cWomen in the age range 22–27.
dAge range 27–32.
eAge range 33–55.
Infections with multiple HPV genotypes were very frequent
being present in 45.7, 8.6, and 18.3% of HPV–DNA positive
migrant women in Apulia, Campania, and Sicily, respectively.
The pooled analysis of three large studies on HPV prevalence
in cervical cancer in Italy included 526 cases from women born
in Italy and 48 cases from women born abroad. HPV sequences
were detected in 95.8% of cases in both cancer groups (504 out
of 526 in native Italian; 46 out of 48 in born abroad) and HPV16
was the most common genotype representing 67.5% (340 out of
504) and 71.7% (33 out of 46) of all infections in native Italian and
born abroad women, respectively. The distribution of HPV geno-
types did not differ significantly between Italian and born abroad
women (Table 4), with the exception of an excess for HPV33 in
immigrants with borderline statistical significance (p= 0.076).
DISCUSSION
The overall HPV prevalence of 51.9% observed among 499
migrant women living in Southern Italy regions such as Apulia,
Campania, and Sicily is much higher compared to the infection fre-
quencies of 13.4%,observed among 3,817 Italian women attending
organized cervical cancer screening, and of 19.7% found in183
Italian women with normal cytology self-referring for gyneco-
logic care (30, 31). Similar findings have been reported in migrant
groups in Spain where the HPV prevalence among migrants from
Colombia, Ecuador, or other Latin American countries was found
three times higher than the 8.2% prevalence in Spanish-born
women (32), and a peak of 61% in HPV prevalence was observed
among sex workers from Eastern Europe (33).
The high burden of HPV infection in migrants may reflect
the high viral prevalence in their country of origin. In fact all
women enrolled in the Apulia Asylum Seekers center, immigrated
mainly from Nigeria, Ivory Cost and Mali, were short-term immi-
grants enrolled soon after their arrival in Italy (23). Moreover,
the nucleotide sequence analysis of HPV16, 52, and 58 amplimers
from samples of African immigrant women showed nucleotide
signatures distinctive of viral variants specifically distributed in
the country of origin of these women (34).
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Table 3 | HPV type-specific prevalence among migrant women from Africa (n = 207), Southern and Eastern Europe (n = 154), Southern and
Central America (n = 8), and Southern Asia (n = 15).
All migrantsa Africa South and East Europe South and Central America Southern Asia
N (%)
HPV-neg 240 (48.1) 116 (56.0) 62 (40.3) 3 (37.5) 4 (26.7)
HPV-pos 259 (51.9) 91 (44.0) 92 (59.7) 5 (62.5) 11 (73.3)
HPV group 1-pos 196 (39.3) 69 (33.3) 77 (50.0) 4 (50.0) 10 (66.7)
HPV-POS BY AGEb
≤20 19 (55.9) 18 (54.5) 1 (100)
21–24 40 (48.2) 28 (41.2) 11 (78.6) 1 (100)
25–29 40 (48.8) 21 (38.9) 15 (71.4) 4 (80.0)
>30 100 (54.9) 24 (49.0) 65 (55.1) 4 (80.0) 7 (70.0)
GROUP 1
16 70 (27.0) 14 (15.4) 47 (51.1) 2 (40.0) 5 (45.5)
18 10 (3.9) 3 (3.3) 1 (20.0) 1 (9.1)
31 22 (8.5) 7 (7.7) 10 (10.9)
33 7 (2.7) 4 (4.4) 1 (1.1) 1 (20.0)
35 9 (3.5) 6 (6.6) 1 (1.1) 1 (20.0)
39 11 (4.2) 5 (5.5) 2 (2.2)
45 10 (3.9) 5 (5.5) 2 (2.2) 1 (9.1)
51 13 (5.0) 5 (5.5) 1 (1.1)
52 14 (5.4) 4 (4.4) 4 (4.3) 1 (9.1)
56 11 (4.2) 4 (4.4) 5 (5.4) 1 (9.1)
58 16 (6.2) 9 (9.9) 4 (4.3) 1 (20.0) 1 (9.1)
59 3 (1.2) 3 (3.3)
GROUP 2–3
6 5 (1.9) 1 (1.1) 2 (2.2)
11 1 (0.4)
26 1 (0.4) 1 (1.1)
32 1 (0.4) 1 (1.1)
40 2 (0.8) 1 (1.1)
42 8 (3.1) 6 (6.6) 1 (1.1) 1 (9.1)
43 1 (0.4)
44 6 (2.3) 1 (1.1) 1 (1.1)
53 22 (8.5) 11 (12.1) 6 (6.5)
54 11 (4.2) 7 (7.7) 1 (1.1)
55 3 (1.2) 3 (3.3)
61 7 (2.7) 6 (6.6) 1 (1.1)
62 5 (1.9) 3 (3.3) 2 (2.2) 1 (20.0)
64 1 (0.4) 1 (1.1)
66 11 (4.2) 5 (5.5) 2 (2.2)
67 4 (1.5) 3 (3.3) 1 (1.1)
68 12 (4.6) 5 (5.5) 2 (2.2)
70 13 (5.0) 7 (7.7) 4 (4.3)
72 2 (0.8) 2 (2.2)
73 3 (1.2) 2 (2.2) 1 (1.1)
74 3 (1.2)
81 10 (3.9) 8 (8.8)
82 5 (1.9) 5 (5.5)
83 7 (2.7) 2 (2.2) 3 (3.3)
84 6 (2.3) 5 (5.5)
90 1 (0.4) 1 (1.1)
cand89 6 (2.3) 3 (3.3)
aThe group of all migrants includes cases from Africa and Southern and Eastern Europe not stratified by origin in the original article (25).
bThe HPV-positive group stratified by age do not include cases by Giovannelli et al. (25).
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Table 4 | HPV type-specific prevalence among cervical cancer cases in
native Italian and abroad born women.
Born in Italy Born abroad Observed/expected p-Value*
N (%)a
HPV-neg 22 (4.2) 2 (41.7)
HPV-pos 504 (95.8) 46 (95.8)
GROUP 1
16 340 (67.5) 33 (71.7) 1.06 0.636
18 57 (11.3) 3 (6.5) 0.57 0.318
31 43 (8.5) 6 (13.0) 1.52 0.314
33 11 (2.2) 3 (6.5) 2.97 0.076
35 11 (2.2) 1 (2.2) 0.99 0.992
39 4 (0.8) 1 (2.2) 2.72 0.349
45 36 (7.1) 3 (6.5) 0.91 0.867
51 7 (1.4) 0 0.420
52 9 (1.2) 0 0.360
56 5 (1.0) 1 (6.5) 2.18 0.464
58 18 (3.6) 1 (6.5) 0.60 0.615
59 5 (1.0) 1 (6.5) 2.18 0.464
GROUP 2–3
6 2 (0.4) 0 0.667
42 2 (0.4) 0 0.667
53 4 (0.8) 0 0.543
66 5 (1.0) 0 0.496
67 1 (0.2) 0 0.762
68 3 (0.6) 0 0.600
70 4 (0.8) 0 0.543
73 9 (1.8) 0 0.360
83 1 (0.2) 0 0.762
aPercentages of individual HPV genotypes are calculated over the total number of
HPV-positive women in each geographical region. The sum of the different HPV
types exceeds the total number of HR HPV-positive due to multiple infections.
*Probability of observed/expected ratio=1, χ2.
A total of 39 viral genotypes were identified including all HPVs
classified as carcinogenic to humans (group 1) (6). The relative
frequencies of individual HPV genotypes are in agreement with
the general distribution found in previous HPV surveys and meta
analysis comprising women with normal cytology worldwide (11,
13, 35). Among HPV-positive migrant women, the fraction of
HPV16 infections varied between 15.4% in Africa and 51.1% in
Southern and Eastern Europe, confirming previous observations
on the heterogeneous distribution of viral genotypes in different
populations (11). Nevertheless, the majority of cervical cancer has
been found positive for HPV16 in all world regions suggesting
a strong long-term risk for CIN3 and invasive cancers following
infection with HPV16 (35).
The high burden of HPV infection in migrants correlates very
well with the increased risk of cervical cancer and CIN3 com-
pared to Italian women. Several studies have documented a higher
occurrence of infection-related cancer, including cervical cancer,
in immigrants from low and medium-income developing coun-
tries compared to the native populations (36–41), often reflecting
the incidence in their countries of origin (37, 41). Crocetti et al.
(16) have reported an increased risk of invasive and in situ cervical
cancer, during the years 2000–2004, among women aged 25–59
who were born in different countries but residing in central Italy.
The incidence of invasive cervical cancer among women born in
Central and South America and the Caribbean (60.5 per 100,000)
and in Central and Eastern Europe (38.3 per 100,000) was sta-
tistically significant higher than that of Italian born women (6
per 100,000) (16, 42). Accordingly, Di Felice et al. (17) recently
reported a higher risk of cervical cancer and CIN3 (SIR= 4.1, 95%
CI= 2.2–6.9; SIR= 2.0, 95% CI 1.7–2.5, respectively) in women
originating from high HPV prevalence countries and residing in
the Reggio Emilia province (Northern Italy) in 2002–2009, com-
pared to Italian women. On the other hand, there was no increased
risk of cervical cancer in women coming from low HPV prevalence
countries, suggesting that HPV prevalence in country of origin is
an important determinant of cervical neoplasia incidence (17).
In Italy immigration is a relatively recent phenomenon: the
proportion of immigrants was less than 0.6% in 1990, 2.3% in
2001 and reached the 6.8% in 20113 (43). This means that most
of immigrants arrived in our country less than 5 years ago. There-
fore, the prevalence of HPV infections, particularly those clinically
relevant, as well as the high risk of cervical cancer may reflect the
figures of their origin countries.
Several studies have shown that the higher cancer incidence
among migrant women living in Italy may be explained either by
the higher HPV infection prevalence or the lower uptake of Pap
test in the country of origin (44, 45). Notably, Di Felice et al. (17)
reported a significant lower ratio of CIN3/cancer among women
from high (ratio 2.6) and low (ratio 3.6) HPV prevalence coun-
tries than in Italian women (ratio 7.4), suggestive of a role of low
screening uptake in cervical cancer incidence among immigrants
(17). Cervical cancer screening programs in Italy are available for
both regular and illegal migrants. Participation in the screenings
is only slightly lower among migrants compared to Italians, 42.2
vs. 46.9% (46), but Pap test coverage is much lower, i.e., 69 vs.
78% (47) due to a minor contribution of spontaneous Pap testing
in immigrants compared to Italians (17). Those regions with an
incomplete activation of organized screening program are contin-
uing and increasing those health inequalities that already affect
immigrant women.
A limitation of the present pooled analysis includes a possi-
ble variation in the HPV genotype-specific sensitivity of different
PCR assays used in the different studies. In fact, in the meta analy-
sis including more than one million women with normal cytology,
it was shown that the adjusted HPV prevalence for the MY09/11-
based consensus PCR primers was significantly higher than that
observed for GP5/6 or GP5+/6+ oligonucleotides, and that the
PCR SPF10 primer system presented the better sensitivity and
the highest HPV detection rate (13). The three PCR assays used
to determine HPV prevalence among migrant women, namely
INNO-LiPA HPV assay (25), Linear Array HPV test (23), and
MY09/MY11 and MGP primer system (24), have been validated
as proficient to detect the 12 oncogenic HPV genotypes in the
HPV LabNet International Proficiency Study (48). Therefore, if
3http://demo.istat.it/
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some HPV genotypes have been underestimated in some study,
they are not among those conferring cancer risk. A further limit
is represented by the different enrollment strategies adopted in
the different studies. In particular women enrolled in Campania
and Sicily were among those self-referring to gynecological outpa-
tient clinics for health assistance, and supposed to be more at risk
for sexual disease; women enrolled in Apulia, instead, voluntary
underwent an offered screening.
On the other hand, a strength of the present study was rep-
resented by the relatively large population sampled in three Ital-
ian regions receiving highest immigration flows from low- and
middle-income countries.
CONCLUSION
The high prevalence of oncogenic HPVs and cervical cancer risk
among migrant women, together with the lower participation in
screening programs, demands for an urgent implementation of
preventive strategies to increase screening and vaccine coverage
and viral monitoring of uncommon HPV genotypes potential
spreading in settled population.
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